HIV drug resistance (HIVDR) in antiretroviral therapy-naive patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high

C Kasang, S Kalluvya, C Majinge, A Stich, J Bodem… - PloS one, 2011 - journals.plos.org
Background The World Health Organization (WHO) has recommended guidelines for a HIV
drug resistance (HIVDR) survey for resource-limited countries. Eligibility criteria for patients …

Magnitude and predictors of HIV-Drug resistance in Africa: A protocol for systematic review and meta-analysis

M Melku, HA Gesesew, PR Ward - Plos one, 2022 - journals.plos.org
Introduction Human Immunodeficiency Virus (HIV) is continued to be a major public health
problem in low-income countries and more importantly in Africa. For the last decade, access …

The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa

SC Inzaule, S Bertagnolio, CM Kityo, M Siwale… - Aids, 2020 - journals.lww.com
Methods: In a multicountry adult cohort initiating nonnucleoside reverse transcriptase
inhibitor-based first-line ART, viremic episodes (viral load≥ 1000 cps/ml) were classified as …

Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based …

I Sikazwe, I Eshun-Wilson, K Sikombe, N Czaicki… - PLoS …, 2019 - journals.plos.org
Background Although the success of HIV treatment programs depends on retention and viral
suppression, routine program monitoring of these outcomes may be incomplete. We used …

Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon

HD Meriki, KA Tufon, MH Afegenwi… - Infectious diseases of …, 2014 - Springer
Background Contemporary data on the immunologic, haematologic and virologic responses
and predictors of virologic failure after initiation of free antiretroviral treatment in Cameroon …

Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and …

N Ndembi, RL Goodall, DT Dunn… - The Journal of …, 2010 - academic.oup.com
Background We investigated virological response and the emergence of resistance in the
Nevirapine or Abacavir (NORA) substudy of the Development of Antiretroviral Treatment in …

Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia

SY Hong, A Jonas, M DeKlerk… - JAIDS Journal of …, 2015 - journals.lww.com
Objective: The World Health Organization (WHO) prospective surveys of acquired HIV drug
resistance (HIVDR) evaluate HIVDR emerging after the first year of antiretroviral therapy …

Viral load suppression and associated factors among HIV patients on antiretroviral treatment in Bulambuli district, eastern Uganda: a retrospective cohort study

P Wakooko, Y Gavamukulya… - Infectious Diseases …, 2020 - journals.sagepub.com
Background: HIV viral load suppression (VLS) is the most important indicator of successful
antiretroviral therapy. In 2016, Bulambuli District started monitoring HIV patients on ART …

Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo

AA Konou, AY Dagnra, N Vidal, M Salou, Z Adam… - AIDs, 2015 - journals.lww.com
Abstract Information on efficacy of long-term antiretroviral treatment (ART) exposure in
resource-limited countries is still scarce. In 767 patients attending routine HIV centers in …

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study

F Kiweewa, A Esber, E Musingye, D Reed, TA Crowell… - PloS one, 2019 - journals.plos.org
Introduction The 2016 WHO consolidated guidelines on the use of antiretroviral drugs
defines HIV virologic failure for low and middle income countries (LMIC) as plasma HIV …